CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities
Net loss	$ (6,251,412)	$ (2,024,039)
Adjustments to reconcile net loss to cash used in operating activities
Reclassification of Organipure capital contribution	(1,000)	0
Depreciation and amortization	116,807	171,098
Non-cash warrant valuation expense	76,249	437,375
Reserving of related party loans	1,464,475	0
Elimination of loss from equity investment	28,619	0
Gain on disposal of assets	0	10,690
Stock based compensation for services	320,400	100,000
Changes in operating assets and liabilities
Trade receivables, net	(323,075)	(159,525)
Accounts receivable, related parties	5,100	(16,481)
Prepaid expenses and other current assets	(156,265)	(202,813)
Prepaid expenses, related parties	(701,332)	0
Inventories	(264,619)	(599,572)
Accounts payable	329,427	253,039
Accounts payable, related parties	44,582	(86,658)
Accrued liabilities	373,267	14,468
Customer deposits	(32,134)	(1,115,266)
Right of use assets and liabilities	(1,314)	0
Net cash used in operating activities	(4,972,225)	(3,217,684)
Cash flows from investing activities
Purchases of property, plant and equipment	(163,184)	(169,398)
Proceeds from disposal of equipment	0	40,000
Franchise fees and licenses related to joint venture	0	(152,609)
Net cash provided by (used in) investing activities	(163,184)	(282,007)
Cash flows from financing activities
Line of Credit	100,000
Equipment loan repayment	0	(300,000)
Long term loan repayment	(5,597)	0
Loans to related parties	(1,750,649)	(70,379)
Proceeds from short-term promissory note, related parties	0	50,000
Repayment of short term note payable	(50,000)
Equity investment in related party	(300,000)	0
Proceeds from the sale of common stock	7,245,000	6,468,000
Offering costs paid in connection with sale of common stock	(634,600)	(607,713)
Cash flows provided by financing activities	4,604,154	5,539,908
Increase (decrease) in cash and cash equivalents	(531,255)	2,040,217
Cash and cash equivalents at beginning of period	548,331	933,469
Cash and cash equivalents at end of period	17,076	2,973,686
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for interest	6,762	0
Cash paid for taxes	132	3,635
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Warrants recorded as prepaid and other assets	$ 374,453	$ 437,375
Conversion of convertible notes payable and accrued interest to common stock	146,940	56,592
Marketing services paid with shares	320,400	100,000
Accounts payable paid with shares	$ 0	$ 100,000
Equipment paid with promissory note	$ 1,724,000
Equity interest in affiliated entity paid with promissory note	1,476,000
Equipment loan paid with shares		1,182,681
Payment for equipment and intangible assets with shares		4,000,000